AU5569500A - Cholesterol biosynthesis inhibitors containing as the active ingredient aromaticcompounds bearing cyclic amino groups - Google Patents
Cholesterol biosynthesis inhibitors containing as the active ingredient aromaticcompounds bearing cyclic amino groupsInfo
- Publication number
- AU5569500A AU5569500A AU55695/00A AU5569500A AU5569500A AU 5569500 A AU5569500 A AU 5569500A AU 55695/00 A AU55695/00 A AU 55695/00A AU 5569500 A AU5569500 A AU 5569500A AU 5569500 A AU5569500 A AU 5569500A
- Authority
- AU
- Australia
- Prior art keywords
- aromaticcompounds
- active ingredient
- amino groups
- cyclic amino
- biosynthesis inhibitors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 title 2
- 239000004480 active ingredient Substances 0.000 title 1
- 125000003277 amino group Chemical group 0.000 title 1
- 150000001491 aromatic compounds Chemical group 0.000 title 1
- 230000015572 biosynthetic process Effects 0.000 title 1
- 235000012000 cholesterol Nutrition 0.000 title 1
- 125000004122 cyclic group Chemical group 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP18087999 | 1999-06-25 | ||
| JP11/180879 | 1999-06-25 | ||
| PCT/JP2000/004183 WO2001000616A1 (en) | 1999-06-25 | 2000-06-26 | Cholesterol biosynthesis inhibitors containing as the active ingredient aromatic compounds bearing cyclic amino groups |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU5569500A true AU5569500A (en) | 2001-01-31 |
Family
ID=16090943
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU55695/00A Abandoned AU5569500A (en) | 1999-06-25 | 2000-06-26 | Cholesterol biosynthesis inhibitors containing as the active ingredient aromaticcompounds bearing cyclic amino groups |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU5569500A (en) |
| WO (1) | WO2001000616A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2433174A1 (en) * | 2000-12-28 | 2002-07-11 | Mochida Pharmaceutical Co., Ltd. | Cholesterol biosynthesis inhibitor containing tricyclic compound having spiro union as effective component |
| WO2004007444A2 (en) | 2002-07-11 | 2004-01-22 | Vicuron Pharmaceuticals, Inc. | N-hydroxyamide derivatives possessing antibacterial activity |
| KR101120414B1 (en) | 2003-04-24 | 2012-04-12 | 인사이트 코포레이션 | Aza spiro alkane derivatives as inhibitors of metalloproteases |
| WO2011029633A1 (en) * | 2009-09-14 | 2011-03-17 | Recordati Ireland Limited | Heterocyclic mglu5 antagonists |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9715892D0 (en) * | 1997-07-29 | 1997-10-01 | Zeneca Ltd | Heterocyclic compounds |
| AU1692399A (en) * | 1997-12-26 | 1999-07-19 | Mochida Pharmaceutical Co., Ltd. | Aromatic compounds having cyclic amino or salts thereof |
| CN1290254A (en) * | 1998-02-05 | 2001-04-04 | 武田药品工业株式会社 | Sulfonamide derivatives process for producing the same and utilization thereof |
-
2000
- 2000-06-26 AU AU55695/00A patent/AU5569500A/en not_active Abandoned
- 2000-06-26 WO PCT/JP2000/004183 patent/WO2001000616A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001000616A1 (en) | 2001-01-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU4215800A (en) | Dynamic server organization | |
| AU4996300A (en) | Method of electroporation-enhanced delivery of active agents | |
| AU7490200A (en) | New and improved formulation for paclitaxel | |
| AU2001260455A1 (en) | Cyclic amino acid derivatives useful as pharmaceutical agents | |
| AU7962200A (en) | Novel indole derivatives and drugs containing the same as the active ingredient | |
| AU5270499A (en) | Formulations having probiotically active microorganisms | |
| HK1049966A1 (en) | Dispersion formulations containing lipase inhibitors. | |
| AU5920999A (en) | Pesticidal compositions containing essential oils with enzyme inhibitors | |
| AU4328800A (en) | Pharmaceutical formulation | |
| AU2002309038A1 (en) | Compositions for transmucosal administration containing coenzyme Q as the active ingredient | |
| AU2186501A (en) | Dynamic deviation | |
| ZA200007415B (en) | Amino acid derivatives and drugs containing the same as the active ingredient. | |
| AU2001288114A1 (en) | Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient | |
| AU6309698A (en) | Drugs containing aminopyridine derivatives as the active ingredient | |
| AU2001232238A1 (en) | Anti-acid-fast bacterial agents containing pyridonecarboxylic acids as the active ingredient | |
| AU5213300A (en) | 2-nh-pyridones and pyrimidones as mrs inhibitors | |
| AU3078000A (en) | Heterocyclic compounds and antitumor agents containing the same as the active ingredient | |
| AU1043201A (en) | Cyclosporin formulation | |
| AU5460800A (en) | Pharmaceutical transdermal compositions | |
| AU1650401A (en) | Oxadiazole derivatives and drugs containing these derivatives as the active ingredient | |
| AU2001277738A1 (en) | Piperidine derivatives and drugs containing these derivatives as the active ingredient | |
| AU2792700A (en) | Pharmaceutical composition containing cyclosporin | |
| AU1650501A (en) | 1,3,4-oxadiazoline derivatives and drugs containing these derivatives as the active ingredient | |
| AU2003227186A1 (en) | Spiro derivatives and adhesion molecule inhibitors comprising the same as the active ingredient | |
| AU5569500A (en) | Cholesterol biosynthesis inhibitors containing as the active ingredient aromaticcompounds bearing cyclic amino groups |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |